0002109738-26-000001.txt : 20260210 0002109738-26-000001.hdr.sgml : 20260210 20260209174236 ACCESSION NUMBER: 0002109738-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260210 DATE AS OF CHANGE: 20260209 EFFECTIVENESS DATE: 20260210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoTerra Inc. CENTRAL INDEX KEY: 0002109738 ORGANIZATION NAME: EIN: 394679403 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573044 FILM NUMBER: 26612691 BUSINESS ADDRESS: STREET 1: 2815 EASTLAKE AVENUE EAST STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 410-382-8042 MAIL ADDRESS: STREET 1: 2815 EASTLAKE AVENUE EAST STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0002109738 CytoTerra Inc. 2815 EASTLAKE AVENUE EAST SUITE 300 SEATTLE WA WASHINGTON 98102 410-382-8042 DELAWARE None None Corporation true 2025 Stephen Eacker 2815 EASTLAKE AVENUE EAST SUITE 300 SEATTLE WA WASHINGTON 98102 Executive Officer Director Jesse Salk 2815 EASTLAKE AVENUE EAST SUITE 300 SEATTLE WA WASHINGTON 98102 Director Sean MacLeod 2815 EASTLAKE AVENUE EAST SUITE 300 SEATTLE WA WASHINGTON 98102 Director Other Technology Decline to Disclose 06b false 2026-01-28 false true true false 0 2000000 1015001 984999 false 13 0 0 0 false CytoTerra Inc. Stephen Eacker Stephen Eacker Chief Executive Officer 2026-02-09